1 Ashford, B. G. et al. Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets. Head Neck 39, 1462-1469, doi:10.1002/hed.24765 (2017).
2 Batsakis, J. G. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol 94, 426-427 (1985).
3 Karia, P. S., Morgan, F. C., Ruiz, E. S. & Schmults, C. D. Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data. JAMA Dermatol 153, 781-788, doi:10.1001/jamadermatol.2017.1680 (2017).
4 Thompson, A. K., Kelley, B. F., Prokop, L. J., Murad, M. H. & Baum, C. L. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. JAMA Dermatol 152, 419-428, doi:10.1001/jamadermatol.2015.4994 (2016).
5 Edge, S. B. & Compton, C. C. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Annals of Surgical Oncology 17, 1471-1474, doi:10.1245/s10434-010-0985-4 (2010).
6 Amin, M. B. et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67, 93-99, doi:10.3322/caac.21388 (2017).
7 Veness, M. J. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol 2007, 80572, doi:10.1155/2007/80572 (2007).
8 Warren, T. A. et al. Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma. Head Neck 38, 824-831, doi:10.1002/hed.23982 (2016).
9 Solares, C. A., Lee, K., Parmar, P., O'Rourke, P. & Panizza, B. Epidemiology of clinical perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 146, 746-751, doi:10.1177/0194599811434897 (2012).
10 Al-Rohil, R. N. et al. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. Cancer 122, 249-257, doi:10.1002/cncr.29738 (2016).
11 Zilberg, C. et al. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 31, 275-287, doi:10.1038/modpathol.2017.128 (2018).
12 Li, Y. Y. et al. Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res 21, 1447-1456, doi:10.1158/1078-0432.CCR-14-1773 (2015).
13 Mueller, S. A. et al. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma. J Invest Dermatol 139, 1449-1458 e1441, doi:10.1016/j.jid.2019.01.008 (2019).
14 Warren, T. A. et al. Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process. Sci Rep 6, 34081, doi:10.1038/srep34081 (2016).
15 Maruya, S. I. et al. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! Oral Oncol 41, 580-588, doi:10.1016/j.oraloncology.2005.01.002 (2005).
16 Gheysarzadeh, A. et al. The insulin-like growth factor binding protein-3 and its death receptor in pancreatic ductal adenocarcinoma poor prognosis. J Cell Physiol 234, 23537-23546, doi:10.1002/jcp.28922 (2019).
17 Brugiere, C. et al. Perineural Invasion in Human Cutaneous Squamous Cell Carcinoma Is Linked to Neurotrophins, Epithelial-Mesenchymal Transition, and NCAM1. J Invest Dermatol 138, 2063-2066, doi:10.1016/j.jid.2018.02.044 (2018).
18 Gil, Z. et al. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst 102, 107-118, doi:10.1093/jnci/djp456 (2010).
19 He, S. et al. GFRalpha1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling. Proc Natl Acad Sci U S A 111, E2008-2017, doi:10.1073/pnas.1402944111 (2014).
20 Na, T. Y., Schecterson, L., Mendonsa, A. M. & Gumbiner, B. M. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci U S A 117, 5931-5937, doi:10.1073/pnas.1918167117 (2020).
21 Deborde, S. et al. Schwann cells induce cancer cell dispersion and invasion. The Journal of Clinical Investigation 126, 1538-1554, doi:10.1172/JCI82658 (2016).
22 Freedman, A. N. et al. Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States. JCO Precision Oncology, 1-13, doi:10.1200/po.18.00169 (2018).
23 Paik, S. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351, 2817-2826, doi:10.1056/NEJMoa041588 (2004).
24 Jensen, M. B. et al. The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer. Breast Cancer Res 20, 79, doi:10.1186/s13058-018-1012-0 (2018).
25 Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47, doi:10.1093/nar/gkv007 (2015).
26 Yu, G. & He, Q. Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst 12, 477-479, doi:10.1039/c5mb00663e (2016).